Total Payments
$44,189
2024 Payments
$524.62
Companies
39
Transactions
306
Medicare Patients
3,036
Medicare Billing
$299,136
Payment Breakdown by Category
Consulting$32,959 (74.6%)
Food & Beverage$5,904 (13.4%)
Travel$5,226 (11.8%)
Education$72.32 (0.2%)
Other$27.07 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,959 | 17 | 74.6% |
| Food and Beverage | $5,904 | 261 | 13.4% |
| Travel and Lodging | $5,226 | 25 | 11.8% |
| Education | $72.32 | 2 | 0.2% |
| Entertainment | $27.07 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Corcept Therapeutics | $33,715 | 97 | $0 (2024) |
| GENZYME CORPORATION | $3,977 | 2 | $0 (2017) |
| BioMarin Pharmaceutical Inc. | $2,457 | 1 | $0 (2022) |
| Radius Health, Inc. | $508.28 | 30 | $0 (2024) |
| Lilly USA, LLC | $436.74 | 19 | $0 (2024) |
| ABBVIE INC. | $363.74 | 23 | $0 (2024) |
| Horizon Therapeutics plc | $267.89 | 7 | $0 (2023) |
| Antares Pharma, Inc. | $258.48 | 16 | $0 (2023) |
| Amgen Inc. | $223.64 | 15 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $184.32 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $524.62 | 21 | Corcept Therapeutics ($85.16) |
| 2023 | $617.59 | 26 | Lilly USA, LLC ($144.08) |
| 2022 | $2,818 | 21 | BioMarin Pharmaceutical Inc. ($2,457) |
| 2021 | $696.89 | 31 | Horizon Therapeutics plc ($143.75) |
| 2020 | $7,660 | 48 | Corcept Therapeutics ($7,104) |
| 2019 | $17,749 | 73 | Corcept Therapeutics ($17,122) |
| 2018 | $5,970 | 44 | Corcept Therapeutics ($5,624) |
| 2017 | $8,154 | 42 | GENZYME CORPORATION ($3,977) |
All Payment Transactions
306 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Endocrinology | ||||||
| 07/09/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $31.55 | General |
| 06/18/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: ENDOCRINE AGENT | ||||||
| 06/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/29/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $24.28 | General |
| 05/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: ENDOCRINE AGENT | ||||||
| 05/07/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Obesity | ||||||
| 04/12/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: ENDOCRINE AGENT | ||||||
| 04/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Bone Health | ||||||
| 03/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $68.85 | General |
| Category: Endocrinology | ||||||
| 03/14/2024 | Chiesi USA, Inc. | MYCAPSSA (Drug) | Food and Beverage | Cash or cash equivalent | $60.01 | General |
| Category: ACROMEGALY | ||||||
| 03/05/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $24.40 | General |
| Category: Endocrinology | ||||||
| 01/31/2024 | Lilly USA, LLC | RETEVMO (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Oncology | ||||||
| 01/24/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 01/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/09/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Endocrinology | ||||||
| 12/08/2023 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug), SIGNIFOR LAR | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/05/2023 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $22.43 | General |
| 11/28/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Obesity | ||||||
| 11/22/2023 | PFIZER INC. | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 604 | 671 | $193,437 | $59,983 |
| 2022 | 7 | 781 | 879 | $255,910 | $79,641 |
| 2021 | 7 | 802 | 895 | $258,328 | $84,002 |
| 2020 | 7 | 849 | 929 | $244,050 | $75,509 |
Total Patients
3,036
Total Services
3,374
Medicare Billing
$299,136
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 269 | 313 | $66,859 | $24,739 | 37.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 95 | $32,775 | $10,947 | 33.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 124 | 131 | $48,208 | $10,160 | 21.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 58 | 58 | $23,483 | $8,558 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 48 | $7,728 | $3,078 | 39.8% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 13 | 14 | $10,304 | $1,389 | 13.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,080 | $1,113 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 360 | 436 | $92,995 | $36,101 | 38.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 182 | 196 | $72,128 | $15,566 | 21.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 85 | 93 | $32,085 | $10,374 | 32.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 70 | 70 | $28,319 | $9,893 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $15,640 | $5,212 | 33.3% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 15 | 15 | $11,040 | $1,600 | 14.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 23 | $3,703 | $895.15 | 24.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 340 | 401 | $83,145 | $33,432 | 40.2% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 198 | 214 | $76,400 | $18,484 | 24.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 82 | 82 | $31,827 | $12,301 | 38.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 58 | 69 | $23,220 | $8,907 | 38.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 48 | 48 | $16,095 | $5,190 | 32.2% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 28 | 28 | $19,360 | $2,964 | 15.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 53 | $8,281 | $2,724 | 32.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 341 | 398 | $73,630 | $26,818 | 36.4% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 215 | 227 | $72,640 | $18,382 | 25.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 90 | 90 | $31,500 | $12,857 | 40.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 75 | 82 | $24,600 | $7,513 | 30.5% |
About Dr. Michael Thomas, MD
Dr. Michael Thomas, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023098506.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Thomas, MD has received a total of $44,189 in payments from pharmaceutical and medical device companies, with $524.62 received in 2024. These payments were reported across 306 transactions from 39 companies. The most common payment nature is "Consulting Fee" ($32,959).
As a Medicare-enrolled provider, Thomas has provided services to 3,036 Medicare beneficiaries, totaling 3,374 services with total Medicare billing of $299,136. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Columbus, OH
- Active Since 01/19/2006
- Last Updated 04/28/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1023098506
Products in Payments
- Korlym (Drug) $33,715
- THYROGEN (Drug) $3,977
- Palynziq (Drug) $2,457
- Tymlos (Biological) $406.48
- FORTEO (Drug) $211.61
- SYNTHROID (Drug) $199.86
- TEPEZZA (Drug) $190.58
- Tirosint (Drug) $161.55
- Strensiq (Drug) $136.74
- SOMAVERT (Drug) $126.00
- XYOSTED (Drug) $117.60
- RECORLEV (Drug) $112.12
- Synthroid (Drug) $107.03
- EVENITY (Biological) $103.01
- NATPARA (PARATHYROID HORMONE) (Drug) $92.40
- NOCDURNA (Drug) $92.11
- SIGNIFOR LAR (Drug) $72.88
- Cryvista (Drug) $68.84
- Macrilen (Biological) $65.55
- RETEVMO (Drug) $62.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Columbus
Elena Christofides, Md, Face, MD, FACE
Endocrinology, Diabetes & Metabolism — Payments: $2.7M
Endocrinology, Diabetes & Metabolism $2.7M
Samuel Anderson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $923,034
Endocrinology, Diabetes & Metabolism $923,034
Ravi Dhawale, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $436,543
Endocrinology, Diabetes & Metabolism $436,543
Kathleen Wyne, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $286,006
Endocrinology, Diabetes & Metabolism $286,006
Dr. Steven Leichter, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $169,186
Endocrinology, Diabetes & Metabolism $169,186
Constantine Kroustos, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $144,793
Endocrinology, Diabetes & Metabolism $144,793